Description
Product details
Zynesp 40 Injection is an erythropoiesis-stimulating medicine used for the management of anaemia associated with chronic kidney disease (CKD) and chemotherapy-related anaemia. It stimulates the bone marrow to increase red blood cell production, helping maintain haemoglobin levels and improve the oxygen-carrying capacity of the blood. Benefits Anaemia Associated with Chronic Kidney Disease Reduced kidney function can affect normal red blood cell production and lead to anaemia. Zynesp 40 Injection supports the formation of red blood cells and may help improve symptoms such as fatigue, weakness and reduced energy. Chemotherapy-Related Anaemia Some cancer treatments can reduce red blood cell and haemoglobin levels. Zynesp 40 may be prescribed for suitable patients receiving chemotherapy to stimulate red blood cell production and support the management of anaemia. How to Use Zynesp 40 Injection should be administered only under the guidance of a qualified healthcare professional. The dose and treatment schedule are determined according to haemoglobin levels, medical condition and individual response to treatment. Possible Side Effects Reported side effects may include: High blood pressure Rash Injection-site pain Breathlessness Cough Peripheral oedema Low blood pressure during certain procedures Convulsions Thromboembolic events Consult your doctor if any side effect persists, becomes severe or causes concern. Important Precautions Regular monitoring of haemoglobin and blood pressure may be required during treatment. Inform your doctor about existing medical conditions, history of blood clots and other medicines being taken.
